- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06173167
Clinical Evaluation of Full Contour Zirconia Chairside CAD/CAM Crowns
March 27, 2024 updated by: Ivoclar Vivadent AG
This investigation will be a randomized, prospective, longitudinal clinical trial to study the clinical performance of a new monolithic, zirconia material with shade, translucency and material graduation for chairside CAD/CAM crowns.
The restorations will be luted either with a self-adhesive luting material or a conventional cement.
The crowns will be evaluated for a period of two years.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dennis J. Fasbinder, DDS
- Phone Number: (734) 647-4450
- Email: djfas@umich.edu
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109-1078
- Recruiting
- University of Michigan School of Dentistry
-
Contact:
- Dennis J Fasbinder
- Phone Number: 734-647-4450
- Email: djfas@umich.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- at least 18 years of age
- at least one carious lesion, defective restoration, or fractured portion of the tooth to be restored on a maxillary or mandibular premolar or molar tooth - Each lesion, fracture, or defective restoration should exhibit sufficient size or loss of tooth structure requiring a full crown restoration.
- tooth should have at least one opposing tooth in occlusion and one adjacent tooth with an intact proximal contact
- No more than ten teeth that are endodontically treated may be included in the study, equally divided between the two groups of crowns. All remaining teeth in the study will test vital and be asymptomatic at the beginning of treatment.
- No more than two restorations will be placed per patient
Exclusion Criteria:
- Sensitive teeth
- Teeth with a history of direct or indirect pulp capping procedures
- Patients with significant untreated dental disease to include periodontitis and/or rampant caries
- Women who self-report that they are possibly pregnant, pregnant, or lactating, as elective dental treatment is not indicated at these times
- Patients with a self-reported history of allergies to the materials to be used in the study including composite resin cements or zirconia restorative materials
- Patients unable to return for the recall appointments
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SpeedCEM Plus luted crowns
crowns delivered with a self-adhesive, self-curing resin cement (SpeedCEM Plus\Ivoclar Vivadent AG)
|
After cavity preparation, the zirconia chairside crown will be placed using SpeedCEM Plus.
The excess will be light cured with Bluephase G4 in PreCure mode (950 mW/cm^2).
After removal of the excess, the luting material margins will be light-cured again for 20s (1200 mW/cm^2).
|
|
Experimental: ZirCAD Cement cemented crowns
crowns delivered with a resin modified glass ionomer cement (ZirCAD Cement\Ivoclar Vivadent AG)
|
After cavity preparation, the zirconia chairside crown will be placed using ZirCAD Cement.
The excess cement will be removed in the gel phase, either following light curing (5 - 10 seconds per segment) or following self-curing (approximately 2 min after placement).
The restoration will be held in position during final curing that is complete 4 min 30 s after placement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short-term Post-operative Sensitivity
Time Frame: 4 weeks
|
assessed by patient's weekly feedback for 4 weeks after the treatment rating sensitivity from 1 "no sensitivity" to 4 "severe discomfort noted routinely with cold or pressure stimulation"
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality Criteria (modified FDI criteria)
Time Frame: 1 year to 2 years
|
assessed following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable" (e.g.
post-operative hypersensitivity, surface lustre, Staining, fracture of material, retension, occlusal contour and wear, and colour match of restorations)
|
1 year to 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Dennis J. Fasbinder, DDS, University of Michigan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 8, 2024
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
December 7, 2023
First Submitted That Met QC Criteria
December 7, 2023
First Posted (Actual)
December 15, 2023
Study Record Updates
Last Update Posted (Actual)
March 28, 2024
Last Update Submitted That Met QC Criteria
March 27, 2024
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- OTCS11686932
- HUM00241710 (Other Identifier: University of Michigan)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Diseases
-
University of California, San FranciscoCompletedOral Hygiene | Plaque, Dental | Caries, DentalUnited States
-
Solventum US LLCTerminatedDental Caries | Tooth Decay | Dental Decay | Pulp Exposure, DentalUnited States
-
Ivoclar Vivadent AGActive, not recruitingCaries, Dental | Class II Dental Restorations | Class I Dental Restorations | Insufficient Dental RestorationLiechtenstein
-
University of JordanCompletedDental Caries | Pulp Disease, Dental | Dental LeakageJordan
-
TIJEN PAMIRActive, not recruitingDental Caries, Dental Pulp Exposure
-
Assiut UniversityRecruiting
-
Ahram Canadian UniversityAl Hayah University In CairoCompletedDental Implantation | Dental Implant | Surgical Dental ProsthesesEgypt
-
University GhentRecruitingDental Caries | Dental PlaqueBelgium
-
Hacettepe UniversityRecruitingPulp Disease, Dental | Dental Caries Extending to PulpTurkey
-
University GhentNot yet recruitingDental Caries (Diagnosis) | Dental Plaque (Diagnosis)Belgium
Clinical Trials on Crowns self-adhesively luted
-
Federal University of PelotasUniversidade Federal de Santa MariaUnknownPost and Core FailureBrazil
-
Istanbul Medipol University HospitalCompletedDental Restoration FailuresTurkey